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Introduction
Insufficiency fractures (IFs) are defined as a type of stress 
fracture, which can occur if a weakened bone, due to 
decreased elastic resistance and demineralization, is stressed 
with normal and/or physiological force. 
Many pathological conditions are often associated with 
IFs, such as osteoporosis (1-4).
Recently, radiation therapy (RT) has been recognized 
as a risk factor for IFs (5) in many malignancies (6-10), 
ranging from 9% to 11.2% in rectal (11), 8.2% to 45.2% 
in cervical (12-14), and up to 6.8% (10) in prostate cancer, 
respectively. The risk factors for RT-induced IFs that have 
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Background: The aim of our work is to assess the potential role of texture analysis (TA), applied to 
computed tomography (CT) simulation scans, in relation to the development of insufficiency fractures (IFs) 
in patients undergoing radiation therapy (RT) for pelvic malignancies. 
Methods: We analyzed patients undergoing pelvic RT from Jan-2010 to Dec-2016, 31 of whom had 
developed IFs of the pelvis. We analyzed CT simulation scans using LifeX Software©, and in particular 
we selected three regions of interest (ROI): L5 body, the sacrum and both the femoral heads. The ROI 
were automatically contoured using the treatment planning software Raystation©. TA parameters included 
parameters from the gray-level histogram, indices from sphericity and from the matrix of GLCM (gray 
level co-occurrence matrix). The IFs patients were matched (1:1 ratio) with control patients who had 
not developed IFs, and were matched for age, sex, type of tumor, menopausal status, RT dose and use of 
chemotherapy. Univariate and multivariate analyses (logistic regression) were used for statistical analysis.
Results: Significant TA parameters on univariate analysis included both parameters from the histogram 
distribution, as well from the matrix of GLCM. On logistic regression analysis the significant parameters 
were L5-energy [P=0.033, odds ratio (OR): 1.997, 95% CI: 1.059–3.767] and FH-Skewness (P=0.014, 
OR: 2.338, 95% CI: 1.191–4.591), with a R2: 0.268. A ROC curve was generated from the binary logistic 
regression, and the AUC was 0.741 (95% CI: 0.627–0.855, P=0.001, S.E.: 0.058).
Conclusions: In our experience, 3D-bone CT TA can be used to stratify the risk of the patients to develop 
radiation-induced IFs. A prospective study will be conducted to validate these findings. 
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been identified include post-menopausal state, older age, 
chemotherapy and female sex (8,11,13,14).
Texture analysis (TA) is able to quantify image 
heterogeneities that may not be appreciated with the 
naked eye, and represents a method based on mathematical 
analysis for the evaluation of gray-level intensity and for 
the position of the pixels within the images, providing 
“texture features”, that represent a quantitative measure of 
various imaging techniques (15). Statistical analysis achieves 
and quantifies both distribution and relationships of the 
gray-level values of the image. Actually, many studies have 
considered TA in several areas of cancer imaging, showing a 
potential application in diagnosis, assessment of response to 
treatment as well as characterization of tumors (16-24). In 
regards of bone physiology, TA has been applied mainly for 
densitometry, leading to the development of the trabecular 
bone score (TBS), an analytical tool for gray-level texture 
measurements calculated on dual X-ray absorptiometry 
(DXA) of the lumbar spine, thus providing information 
related to trabecular architecture (25-27).
We have previously studied the efficacy of bone TA, 
using a home-made ImageJ macro and selecting only two 
2D ROI (the vertebral body of L5 and the femoral head) in 
a case-control study (28,29). 
With these premises, we have investigated in the 
present study the potential role of TA based on 3D ROI, 
automatically contoured using the treatment planning 
software Raystation©. TA parameters were calculated using 
LifeX Software© (30), and included parameters from the 
gray-level histogram and from the matrix of GLCM (gray 
level co-occurrence matrix). 
Methods
Patients 
IF cohort of patients (IF-p)
From January 2009 to December 2016, 31 patients that 
were previously treated for pelvic malignancies developed 
pelvic IFs during the follow-up. We collected all the clinical 
data, as well as the pathological and dosimetric information, 
for the present study. 
The IF-p series included 14 patients (46%) with 
endometrial or cervical cancer, 15 patients (48%) with anal 
or rectal cancer and 2 (6%) with prostate or bladder tumors.
A CT simulation for treatment planning calculations 
was done before RT. Previous fractures of the pelvic bone 
and any tumor recurrence were considered as a cause of 
exclusion. 
In this regard, we have excluded twelve patients from 
this analysis (five patients showed evidence of IFs before 
the radiation treatment and seven patients developed bone 
tumor recurrence). 
Controlled patients cohort (C-p)
The IF-p patients were compared (1:1 ratio) with the 
C-p series, which were similarly patients submitted 
to pelvic irradiation in our institution in the same 
time-lapse, but not developing IFs. Each IF-p patient 
was matched with one C-p patient, for the criteria 
of sex, menopausal status, age, localization of tumor, 
chemotherapy and RT dose. The exclusion criteria were 
identical.
In order to limit biases, we also considered the time-lapse 
of RT administration (Jan 2009 to Dec 2012 vs. Jan 2013 
to Dec 2016), the RT total doses and the RT technique 
[intensity-modulated RT (IMRT) vs. three-dimensional 
conformal RT (3D-CRT)].
Radiotherapy and chemotherapy treatment
RT was given with a Linear Accelerator, with 6 or 
15 MeV photon beams. 3D-CRT or IMRT techniques were 
chosen according to the clinician choice. Target volumes 
and organs at risk were identified by diagnostic CT and 
contoured on simulation CT.
Chemotherapy was administered concurrently with, 
or sequentially to, RT, employing standard association of 
platinum, fluoropyrimidine compounds, mitomycin and 
taxanes, according to international guidelines.
Specifically, patients with cervical cancer underwent 
chemotherapy with weekly cisplatin (40 mg/m2), patients 
with rectal  cancer underwent chemotherapy with 
capecitabine (825 mg/m2, twice daily for 5 days/week) daily 
throughout the radiotherapy course, and patients with 
anal canal cancer underwent chemotherapy with 5-FU 
(1,000 mg/m2/day) by continuous infusion for 4 days and 
MMC (10 mg/m2) intravenous bolus for two cycles during 
the course of RT.
Authorization for the retrospective analysis was given by 
the Internal Institutional Review Board. 
Each patient signed an informed consent both for the 
treatments and for the anonymous use of clinical data. All 
procedures were in compliance with the ethical statements 
of the Helsinki Declaration (1964, amended most recently 
in 2008).
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Follow-up
After completion of treatment, all patients underwent 
scheduled follow-up visits, according to the primary 
tumor. In patients with gynecological, gastrointestinal and 
bladder malignancies, an imaging with CT and/or MRI was 
performed at 4–6 and 12–16 weeks after the completion of 
RT, then every 6 months. In patients with prostate cancer, 
diagnostic CT and/or MRI was obtained only if justified by 
a rise of the PSA value and/or by emerging symptoms or 
physical signs of recurrence or complications.
The MRI examination was obtained with a 1.5-T system, 
Signa Excite HD, GE Healthcare, Milwaukee, WI, USA, 
whereas the CT was performed with a 64-detector row CT 
scanner (Discovery 750 HD, GE Healthcare, Milwaukee, 
WI, USA).
All the patients underwent a physical examination, 
chemistry and blood counts every 3 months. 
Assessment of IFs
IFs development was confirmed at CT or MR imaging, by 
an expert radiologist (Salvatore Francesco Carbone), with 
15 years’ experience in the oncologic field. CT findings 
of IF included sclerotic linear changes or fracture lines, 
whereas MRI findings included both on T1 and T2-
weighted images the presence of signal intensity changes in 
the bones of >5 mm (8).
In all the patients with IFs the simulation CT scan was 
reviewed, in order to exclude the patients that showed pre-
existent fractures. 
CT simulation
CT simulation was performed before RT, with a 16 slice 
CT-scanner (slice thickness 2.5 mm, beam pitch of 1.375, 
reconstruction interval 2.5 mm, tube voltage of 120 kVp and 
reference mAs ranging from 100 to 440 mA, Index Noise 10). 
Image analysis
We analyzed three regions of interest (ROI) on CT 
simulation: the vertebral  body of L5, the sacrum 
(S1–S3) and the femoral heads (Figure 1). Each ROI 
was automatically contoured using a treatment planning 
contouring workstation (RayStation©) and validated by a 
radiation oncologist (Valerio Nardone).
The TA was performed using a LifeX© (30), and 
included features of gray-level co-occurrence matrix 
(GLCM), sphericity and indices from the gray-level 
histogram. For the femoral heads ROI we calculated the 
mean of the two ROI. 
Statistics
The TA parameters, as described above, were correlated with 
the development of IFs by univariate (Pearson correlation). 
We analyzed the correlation between the significant TA 
parameters and, if a correlation larger than 0.80 was observed, 
then the variable with the lowest univariable correlation with 
the endpoint was omitted, to avoid the risk of overfitting 
the model and of multicollinearity (31) in the multivariate 
analysis (binary logistic regression). After performing the 
multivariate analysis the ROC Curves with these parameters 
were also carried out. The statistical analysis was performed 
using the SPSS software 23.0.
Results
The characteristics of both the cohorts of IF-p and C-p, 
with the localizations of the IFs are reported in Table 1. IFs 
occurred in different pelvic bones, with 17 patients (55%) 
developed multiple IFs.
The median follow-up period was equal to 43.46 months 
(mean 47.21 months, SD 24.26 months, range 12–84 months).
Regarding the enrollment time-lapse, 15 out of 
31 patients (48%) in IF-p series and 16 out of 31 patients 
(52%) in C-p series were enrolled from Jan 2009 to 
Dec 2012, whereas 16 out of 31 patients (52%) in IF-p 
series and 15 out of 31 patients (48%) in C-p series were 
enrolled from Jan 2013 to Dec 2016 (P>0.05). Regarding 
the RT technique 16 out of 31 patients (52%) in IF-p 
series and 17 out of 31 patients (55%) in C-p series 
underwent intensity modulated radiation therapy (IMRT), 
whereas 15 out of 31 patients (48%) in IF-p series and 
14 out of 31 patients (45%) in C-p series underwent 
3D-conformal RT, 3D-CRT (P>0.05). The period of 
enrollment, as well as the radiation doses between IF-p 
and C-p were well balanced between the groups (see the 
results reported in Table 1).
Univariate analysis
We performed a Pearson correlation analysis between the 
TA parameters and the development of IFs.
Significant TA parameters included: L5-kurtosis (P=0.049), 
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L5-energy (P=0.007), L5-GLCM-energy (P=0.023), 
sacrum-kurtosis (P=0.034), sacrum-compacity (P=0.039, 
this parameters is a measure of compactness of the volume), 
FH-kurtosis (P=0.005), FH-skewness (P=0.001), FH-
energy (P=0.005), FH-GLCM-homogeneity (P=0.006), FH-
GLCM-energy (P=0.020) (Tables 2,3 and Figure 2). 
Multivariate analysis 
The TA parameters that resulted significantly at univariate 
analysis were normalized and tested for co-correlation. The 
parameters L5-GLCM-energy, FH-kurtosis, FH-energy 
were omitted, to avoid the risk of overfitting the model and 
of multicollinearity (31) in the multivariate analysis. 
We performed a logistic regression analysis with the 
group as the dependent variable and all the normalized 
texture parameters, plus all relevant confounding variables 
(sex, radiation doses, and chemotherapy). 
The variables that resulted significant were L5-energy 
[P=0.033, odds ratio (OR): 1.997, 95% CI: 1.059–3.767] and 
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Figure 1 Examples of ROI and histograms of the pixel distribution (CT simulation DICOM images): (A) femoral head ROI; (B) sacrum 
ROI; (C) L5 ROI. ROI, regions of interest; DICOM, Digital Imaging and Communications in Medicine.
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FH-skewness (P=0.014, OR: 2.338, 95% CI: 1.191–4.591), 
with a R2: 0.268 (Tables 2,3).
A ROC curve was generated from the binary logistic 
regression, the AUC was 0.741 (95% CI: 0.627–0.855, 
P=0.001, S.E.: 0.058) (Figure 3). 
Discussion
We have previously studied (28,29) the role of bone TA, 
with an in-house 2D software, and we have decided to 
explore the potential role of 3D Bone TA. Moreover, we 
tested the possibility of automatically obtain 3D ROI 
with the treatment planning contouring workstation 
(Raystation©).
Although the LifeX Software© (30) is able to calculate 
parameters of gray-level co-occurrence matrix (GLCM), 
neighbourhood gray-level dependence matrix (NGLDM), 
gray-level run length matrix (GLRLM), gray-level zone 
length matrix (GLZLM), sphericity and indices from the 
gray-level histogram, we decided to use only parameters 
Table 1 Characteristics of patients in the insufficiency fracture (IF-p) and control (C-p) series 
Characteristics of patients IF-p series C-p series
Sex
Male 9 (29%) 9 (29%)
Female 22 (71%) 22 (71%)
Age: mean (range) 65.7±10.21 (range, 30–81) years 64.9±11.24 (range, 32–80) years
Menopausal status
Pre-menopausal 8 (36%) 7 (32%)
Post-menopausal 14 (64%) 15 (68%)
Disease
Gynecological 14 (46%) 14 (46%)
Gastrointestinal 15 (48%) 15 (48%)
Urological 2 (6%) 2 (6%)
Chemotherapy Yes: 19 (61%) Yes: 19 (61%)
No: 12 (39%) No: 12 (39%)
RT target dose (PTV): mean (range) 5,030±510 (range, 4,500–5,940) cGy 5,050±540 (range, 4,500–5,940) cGy
Localization of the IFs
Sacroiliac joints 18 (58%)
Pubis 7 (23%)
Acetabulum 4 (13%)
Sacral body 7 (23%)
Lumbar vertebrae 6 (19%)
RT technique
IMRT 16/31 (52%) 17/31 (55%)
3D/CRT 15/31 (48%) 14/31 (45%)
Enrollment period
Jan 2009 to Dec 2012 15/31 (48%) 16/31 (52%)
Jan 2013 to Dec 2016 16/31 (52%) 15/31 (48%)
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L5-kurtosis
FH-kurtosis
P value: 0.049
P value: 0.005
C-p             IF-p
C-p             IF-p C-p             IF-p C-p             IF-p C-p             IF-p C-p             IF-p
C-p             IF-p C-p             IF-p C-p             IF-p C-p             IF-p
P value: 0.001 P value: 0.005 P value: 0.006 P value: 0.020
P value: 0.007 P value: 0.023 P value: 0.034 P value: 0.039
L5-energy
FH-skewness FH-energy FH-GLCM-homogeneity FH-GLCM-energy
L5-GLCM-energy Sacrum-kurtosis Sacrum-compacity
Figure 2 Box Plot in IF-p and C-p patients (univariate analysis). IF, insufficiency fracture. IF-p, insufficiency fracture cohort of patients; C-p, 
controlled patients cohort.
Table 2 Pearson univariate analysis
TA parameters IF-p series (mean ± SD) C-p series (mean ± SD) P value
Kurtosis (L5) 5.98±1.92 5.23±1.23 0.049
Energy (L5) 0.050±0.0098 0.044±0.006 0.007
GLCM-energy (L5) 0.0049±0.0018 0.0041±0.0011 0.023
Kurtosis (sacrum) 6.791±2.42 5.78±1.50 0.034
Compacity (sacrum) 3.86±1.26 3.40±0.50 0.039
Kurtosis (FH) 6.58±1.60 5.73±0.85 0.005
Skewness (FH) 1.86±0.25 1.68±0.19 0.001
Energy (FH) 0.041±0.0059 0.038±0.0041 0.005
GLCM-homogeneity (FH) 0.38±0.026 0.37±0.020 0.006
GLCM-energy (FH) 0.0046±0.0013 0.0040±0.00098 0.020
TA, texture analysis; GLCM, gray-level co-occurrence matrix; IF, insufficiency fracture; FH, femoral head.
Table 3 Binary logistic regression analysis (normalized odds ratio)
Parameter P value Odds ratio 95% CI
Energy (L5) 0.033 1.997 1.059–3.767
Skewness (FH) 0.014 2.338 1.191–4.591
FH, femoral head.
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from gray-level histogram, sphericity and GLCM matrix, 
to reduce the number of TA variables, including TA indices 
that were already used in the imaging of trabecular bone 
structure (32).
At this regard, the major novelties of this paper, in 
comparison to our previous work (28), are the 3D TA, the 
automatic contouring of the ROI and the higher number of 
texture parameters analysed.
Our results showed a co-correlation between many 
variables, as well as the significance of the same TA variables 
between the different ROI (energy, kurtosis), and this aspect 
increases the validity of our results. 
The TA variables that resulted significant at binary 
logistic regression were L5-energy and FH-skewness. 
Energy represents a measure of the uniformity of the 
distribution, and is significantly higher in IF-p than C-p. 
This parameter is inversely correlated to the entropy, in 
accordance with previous works (28,33,34). This might be 
explained by the fibers being more marked in the control 
group, with an increase in the randomness of the pixel 
values, and eventually an increase in the entropy and a 
decrease in energy.
Skewness, on the other hand, measures the asymmetry 
of the gray-level distribution in the histogram, and this 
parameter was higher in IF-p than C-p. This result could be 
correlated to a lower density (35) and mineralization of the 
bone, thus reflecting a higher asymmetry in the histogram.
We have summarized the various studies of bone TA in 
Table 4.
However, the interpretation of TA parameters on the 
grounds of bone pathophysiology is incomplete, thus our 
study is still awaiting an exhaustive scientific background. 
In fact, radiation-induced bone damage has been 
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Figure 3 ROC curve generated from binary logistic regression. 
AUC 0.741 (95% CI: 0.627–0.855, P=0.001, S.E.: 0.058). ROC, 
receiver operating characteristic curve; AUC, area under the curve.
Table 4 Comparison of different studies regarding bone texture analysis
References Texture parameters Findings
Current work L5-energy Measure of the uniformity of the distribution, and is 
higher in patients developing IFs
FH-skewness Measure of the asymmetry of the gray-level 
distribution in the histogram, and is higher in 
patients developing IFs
Nardone et al. (28) L5—entropy and uniformity Entropy was lower in IFs, and uniformity was higher
FH—mean and standard deviation CT Mean and standard deviation were significantly 
lower in the IF-p
Uezono et al. (35) CT density of bone and bone marrow Lower density of bone and bone marrow in the IF-p
Harvey et al. (25) TBS, a measure of grey-level texture measurements on 
lumbar spine dual X-ray absorptiometry (DXA) images
Measure of trabecular microarchitecture, is lower in 
patients developing IFs
Rachidi et al. (33) Mean, standard deviation and entropy All these parameters were significantly lower in 
patients developing IFs
Thevenot et al. (34) Entropy Entropy was lower in IF-patients
IF, insufficiency fracture.
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described since the early years of the twentieth century, 
but the pathophysiology is still unclear. Irradiation seems 
to reduce osteoblast number, arrest osteoblast cell cycle 
progression and promote apoptosis, leading to a reduced 
bone formation (36-38). Data for osteoclasts effect are in 
some way contradictory (39,40), whereas the damages on 
bone matrix and on the vascular supply are established 
(41,42). The combination of these effects results in a 
reduction in the bone mineral density (BMD) in patients 
undergoing pelvic RT (43).
The incidence of IF seems to be higher than expected, 
although there are many discrepancies in the various 
study (5,10-14,44-46), probably due to the differences in 
the follow-up, as the choice of imaging may increase the 
detection of asymptomatic IFs. One study reported 89% 
of patients had findings compatible with IF after pelvic RT 
using magnetic resonance imaging (47), while another study 
reported 34% using bone scintigraphy (48).
It is noteworthy that currently there is no recommendation 
for the diagnosis and the management of radiation-related IF 
in patients undergoing pelvic radiotherapy.
Very recently (25-27), the TBS measurement of 
gray level texture on DXA images has provided some 
information on microarchitecture of the trabecular bone, 
and these parameters seem associated with an increase in 
both prevalent and incident fractures. These information, 
also, seem to be independent from the clinical risk factors 
and BMD. 
Limitations of the study
Although our method of TA has improved with the use of 
automatically contoured ROI, 3D TA and a higher number 
of TA parameters, our results still need methodological and 
technical refinements, as wells as a validation in larger series 
and prospective trials. 
The low number of patients enrolled, as well as the 
matched analysis comparison, also represent a limit of our 
study.
Conclusions
Insufficiency fractures represent an important cause 
of morbidity for cancer survivors undergone pelvic 
radiotherapy and there is a need to develop robust clinical 
interventions that are evidence-based.
Our results appear to be promising since the knowledge 
of the predictive factors of this kind of RT toxicity could 
drive the selection of the best appropriate preventions in 
the population at risk. 
We’re planning to start a prospective trial, integrating 
bone mineralometry and serum markers, to further 
substantiate this field of investigation.
Acknowledgements
None.
Footnote
Conflicts of Interest: The authors have no conflicts of interest 
to declare.
Ethical Statement: Authorization for the retrospective 
analysis was given by the Internal Institutional Review 
Board. Each patient signed an informed consent both 
for the treatments and for the anonymous use of clinical 
data. All procedures were in compliance with the ethical 
statements of the Helsinki Declaration (1964, amended 
most recently in 2008). 
References
1. Pacheco R, Stock H. Effects of radiation on bone. Curr 
Osteoporos Rep 2013;11:299-304.
2. Pentecost RL, Murray RA, Brindley HH. Fatigue, 
Insufficiency, and Pathologic Fractures. JAMA 
1964;187:1001-4.
3. Peh WC, Gough AK, Sheeran T, Evans NS, Emery P. 
Pelvic insufficiency fractures in rheumatoid arthritis. Br J 
Rheumatol 1993;32:319-24.
4. Finiels H, Finiels PJ, Jacquot JM, Strubel D. Fractures of 
the sacrum caused by bone insufficiency. Meta-analysis of 
508 cases. Presse Med 1997;26:1568-73.
5. Baxter NN, Habermann EB, Tepper JE, Durham SB, 
Virnig BA. Risk of pelvic fractures in older women 
following pelvic irradiation. JAMA 2005;294:2587-93.
6. Huh SJ, Kim B, Kang MK, Lee JE, Lim DH, Park W, 
Shin SS, Ahn YC. Pelvic insufficiency fracture after 
pelvic irradiation in uterine cervix cancer. Gynecol Oncol 
2002;86:264-8.
7. Shih KK, Folkert MR, Kollmeier MA, Abu-Rustum 
NR, Sonoda Y, Leitao MM Jr, Barakat RR, Alektiar KM. 
Pelvic insufficiency fractures in patients with cervical 
and endometrial cancer treated with postoperative pelvic 
radiation. Gynecol Oncol 2013;128:540-3.
22 Nardone et al. 3D bone texture analysis predicts insufficiency fractures
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2018;8(1):14-24qims.amegroups.com
8. Tokumaru S, Toita T, Oguchi M, Ohno T, Kato 
S, Niibe Y, Kazumoto T, Kodaira T, Kataoka M, 
Shikama N, Kenjo M, Yamauchi C, Suzuki O, Sakurai 
H, Teshima T, Kagami Y, Nakano T, Hiraoka M, 
Mitsuhashi N, Kudo S. Insufficiency fractures after 
pelvic radiation therapy for uterine cervical cancer: an 
analysis of subjects in a prospective multi-institutional 
trial, and cooperative study of the Japan Radiation 
Oncology Group (JAROG) and Japanese Radiation 
Oncology Study Group (JROSG). Int J Radiat Oncol 
Biol Phys 2012;84:e195-200.
9. Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz 
JM. Impact of clinical and therapeutic factors on major 
late complications after radiotherapy with or without 
concomitant chemotherapy for anal carcinoma. Int J 
Radiat Oncol Biol Phys 1997;39:1099-105.
10. Igdem S, Alco G, Ercan T, Barlan M, Ganiyusufoglu K, 
Unalan B, Turkan S, Okkan S. Insufficiency fractures after 
pelvic radiotherapy in patients with prostate cancer. Int J 
Radiat Oncol Biol Phys 2010;77:818-23.
11. Kim HJ, Boland PJ, Meredith DS, Lis E, Zhang Z, Shi 
W, Yamada YJ, Goodman KA. Fractures of the sacrum 
after chemoradiation for rectal carcinoma: incidence, risk 
factors, and radiographic evaluation. Int J Radiat Oncol 
Biol Phys 2012;84:694-9.
12. Ogino I, Okamoto N, Ono Y, Kitamura T, Nakayama H. 
Pelvic insufficiency fractures in postmenopausal woman 
with advanced cervical cancer treated by radiotherapy. 
Radiother Oncol 2003;68:61-7.
13. Ikushima H, Osaki K, Furutani S, Yamashita K, Kishida 
Y, Kudoh T, Nishitani H. Pelvic bone complications 
following radiation therapy of gynecologic 
malignancies: clinical evaluation of radiation-
induced pelvic insufficiency fractures. Gynecol Oncol 
2006;103:1100-4.
14. Oh D, Huh SJ, Nam H, Park W, Han Y, Lim do H, 
Ahn YC, Lee JW, Kim BG, Bae DS, Lee JH. Pelvic 
insufficiency fracture after pelvic radiotherapy for cervical 
cancer: analysis of risk factors. Int J Radiat Oncol Biol 
Phys 2008;70:1183-8.
15. Kato H, Kanematsu M, Zhang X, Saio M, Kondo 
H, Goshima S, Fujita H. Computer-aided diagnosis 
of hepatic fibrosis: preliminary evaluation of MRI 
texture analysis using the finite difference method and 
an artificial neural network. AJR Am J Roentgenol 
2007;189:117-22.
16. Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K. 
Tumour heterogeneity in oesophageal cancer assessed by 
CT texture analysis: preliminary evidence of an association 
with tumour metabolism, stage, and survival. Clin Radiol 
2012;67:157-64.
17. Huang YL, Chen JH, Shen WC. Diagnosis of hepatic 
tumors with texture analysis in nonenhanced computed 
tomography images. Acad Radiol 2006;13:713-20.
18. Nardone V, Tini P, Biondi M, Sebaste L, Vanzi E, 
De Otto G, Rubino G, Carfagno T, Battaglia G, 
Pastina P, Cerase A, Mazzoni LN, Banci Buonamici 
F, Pirtoli L. Prognostic Value of MR Imaging Texture 
Analysis in Brain Non-Small Cell Lung Cancer Oligo-
Metastases Undergoing Stereotactic Irradiation. Cureus 
2016;8:e584.
19. Nardone V, Tini P, Nioche C, Biondi M, Sebaste L, 
Mazzei MA, Banci Buonamici F, Pirtoli L. Texture 
analysis of parotid gland as a predictive factor of radiation 
induced xerostomia: A subset analysis. Radiother Oncol 
2017;122:321.
20. Nardone V, Tini P, Nioche C, Mazzei MA, Carfagno 
T, Battaglia G, Pastina P, Grassi R, Sebaste L, Pirtoli 
L. Texture analysis as a predictor of radiation-induced 
xerostomia in head and neck patients undergoing IMRT. 
Radiol Med 2018. [Epub ahead of print]. doi: 10.1007/
s11547-017-0850-7.
21. Giganti F, Marra P, Ambrosi A, Salerno A, Antunes S, 
Chiari D, Orsenigo E, Esposito A, Mazza E, Albarello L, 
Nicoletti R, Staudacher C, Del Maschio A, De Cobelli F. 
Pre-treatment MDCT-based texture analysis for therapy 
response prediction in gastric cancer: Comparison with 
tumour regression grade at final histology. Eur J Radiol 
2017;90:129-37.
22. Giganti F, Antunes S, Salerno A, Ambrosi A, Marra P, 
Nicoletti R, Orsenigo E, Chiari D, Albarello L, Staudacher 
C, Esposito A, Del Maschio A, De Cobelli F. Gastric 
cancer: texture analysis from multidetector computed 
tomography as a potential preoperative prognostic 
biomarker. Eur Radiol 2017;27:1831-9.
23. Narang S, Kim D, Aithala S, Heimberger AB, Ahmed 
S, Rao D, Rao G, Rao A. Tumor image-derived texture 
features are associated with CD3 T-cell infiltration status 
in glioblastoma. Oncotarget 2017;8:101244-54.
24. Chee CG, Kim YH, Lee KH, Lee YJ, Park JH, Lee 
HS, Ahn S, Kim B. CT texture analysis in patients with 
locally advanced rectal cancer treated with neoadjuvant 
chemoradiotherapy: A potential imaging biomarker 
for treatment response and prognosis. PLoS One 
2017;12:e0182883.
25. Harvey NC, Gluer CC, Binkley N, McCloskey EV, Brandi 
23Quantitative Imaging in Medicine and Surgery, Vol 8, No 1 February 2018
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2018;8(1):14-24qims.amegroups.com
ML, Cooper C, Kendler D, Lamy O, Laslop A, Camargos 
BM, Reginster JY, Rizzoli R, Kanis JA. Trabecular 
bone score (TBS) as a new complementary approach 
for osteoporosis evaluation in clinical practice. Bone 
2015;78:216-24.
26. Bousson V, Bergot C, Sutter B, Thomas T, Bendavid S, 
Benhamou CL, Blain H, Brazier M, Breuil V, Briot K, 
Chapurlat R, Chapuis L, Cohen Solal M, Fardellone 
P, Feron JM, Gauvain JB, Laroche M, Legrand E, 
Lespessailles E, Linglart A, Marcelli C, Roux C, 
Souberbielle JC, Tremollieres F, Weryha G, Cortet 
B, Groupe de Recherche et d'Information sur les O. 
Trabecular Bone Score: Where are we now? Joint Bone 
Spine 2015;82:320-5.
27. Di Gregorio S, Del Rio L, Rodriguez-Tolra J, Bonel E, 
Garcia M, Winzenrieth R. Comparison between different 
bone treatments on areal bone mineral density (aBMD) 
and bone microarchitectural texture as assessed by the 
trabecular bone score (TBS). Bone 2015;75:138-43.
28. Nardone V, Tini P, Carbone SF, Grassi A, Biondi M, 
Sebaste L, Carfagno T, Vanzi E, De Otto G, Battaglia G, 
Rubino G, Pastina P, Belmonte G, Mazzoni LN, Banci 
Buonamici F, Mazzei MA, Pirtoli L. Bone texture analysis 
using CT-simulation scans to individuate risk parameters 
for radiation-induced insufficiency fractures. Osteoporos 
Int 2017;28:1915-23.
29. Nardone V, Tini P, Sebaste L, Biondi M, Banci Buonamici 
F, Pirtoli L. Bone structure texture analysis as a potential 
tool to estimate radiation induced insufficiency fracture 
risk. Radiother Oncol 2016;120:184.
30. Nioche C, Orlhac F, Boughdad S, Reuze S, Soussan 
M, Robert C, Barakat C, Buvat I. A freeware for tumor 
heterogeneity characterization in PET, SPECT, CT, MRI 
and US to accelerate advances in radiomics. J Nucl Med 
2017;58:Abstrat 1316.
31. van der Schaaf A, Xu CJ, van Luijk P, Van't Veld AA, 
Langendijk JA, Schilstra C. Multivariate modeling of 
complications with data driven variable selection: guarding 
against overfitting and effects of data set size. Radiother 
Oncol 2012;105:115-21.
32. Shirvaikar M, Huang N, Dong XN. The Measurement 
of Bone Quality Using Gray Level Co-Occurrence 
Matrix Textural Features. J Med Imaging Health Inform 
2016;6:1357-62.
33. Rachidi M, Marchadier A, Gadois C, Lespessailles E, 
Chappard C, Benhamou CL. Laws' masks descriptors 
applied to bone texture analysis: an innovative and 
discriminant tool in osteoporosis. Skeletal Radiol 
2008;37:541-8.
34. Thevenot J, Hirvasniemi J, Pulkkinen P, Maatta M, 
Korpelainen R, Saarakkala S, Jamsa T. Assessment 
of risk of femoral neck fracture with radiographic 
texture parameters: a retrospective study. Radiology 
2014;272:184-91.
35. Uezono H, Tsujino K, Moriki K, Nagano F, Ota Y, Sasaki 
R, Soejima T. Pelvic insufficiency fracture after definitive 
radiotherapy for uterine cervical cancer: retrospective 
analysis of risk factors. J Radiat Res 2013;54:1102-9.
36. Sakurai T, Sawada Y, Yoshimoto M, Kawai M, Miyakoshi J. 
Radiation-induced reduction of osteoblast differentiation 
in C2C12 cells. J Radiat Res 2007;48:515-21.
37. Gal TJ, Munoz-Antonia T, Muro-Cacho CA, Klotch DW. 
Radiation effects on osteoblasts in vitro: a potential role 
in osteoradionecrosis. Arch Otolaryngol Head Neck Surg 
2000;126:1124-8.
38. Szymczyk KH, Shapiro IM, Adams CS. Ionizing radiation 
sensitizes bone cells to apoptosis. Bone 2004;34:148-56.
39. Sawajiri M, Mizoe J, Tanimoto K. Changes in osteoclasts 
after irradiation with carbon ion particles. Radiat Environ 
Biophys 2003;42:219-23.
40. Willey JS, Lloyd SA, Robbins ME, Bourland JD, 
Smith-Sielicki H, Bowman LC, Norrdin RW, Bateman 
TA. Early increase in osteoclast number in mice after 
whole-body irradiation with 2 Gy X rays. Radiat Res 
2008;170:388-92.
41. Green DE, Adler BJ, Chan ME, Lennon JJ, Acerbo AS, 
Miller LM, Rubin CT. Altered composition of bone as 
triggered by irradiation facilitates the rapid erosion of the 
matrix by both cellular and physicochemical processes. 
PLoS One 2013;8:e64952.
42. Scheller EL, Rosen CJ. What's the matter with MAT? 
Marrow adipose tissue, metabolism, and skeletal health. 
Ann N Y Acad Sci 2014;1311:14-30.
43. Hui SK, Khalil A, Zhang Y, Coghill K, Le C, Dusenbery 
K, Froelich J, Yee D, Downs L. Longitudinal assessment 
of bone loss from diagnostic computed tomography scans 
in gynecologic cancer patients treated with chemotherapy 
and radiation. Am J Obstet Gynecol 2010;203:353.e1-7.
44. Kwon JW, Huh SJ, Yoon YC, Choi SH, Jung JY, Oh 
D, Choe BK. Pelvic bone complications after radiation 
therapy of uterine cervical cancer: evaluation with MRI. 
AJR Am J Roentgenol 2008;191:987-94.
45. Reginelli A, Silvestro G, Fontanella G, Sangiovanni A, 
Conte M, Nuzzo I, Calvanese M, Traettino M, Ferraioli 
P, Grassi R, Manzo R, Cappabianca S. Validation of DWI 
in assessment of radiotreated bone metastases in elderly 
24 Nardone et al. 3D bone texture analysis predicts insufficiency fractures
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2018;8(1):14-24qims.amegroups.com
Cite this article as: Nardone V, Tini P, Croci S, Carbone 
SF, Sebaste L, Carfagno T, Battaglia G, Pastina P, Rubino 
G, Mazzei MA, Pirtoli L. 3D bone texture analysis as a 
potential predictor of radiation-induced insufficiency fractures. 
Quant Imaging Med Surg 2018;8(1):14-24. doi: 10.21037/
qims.2018.02.01
patients. Int J Surg 2016;33 Suppl 1:S148-53.
46. Arrigoni F, Bruno F, Zugaro L, Natella R, Cappabianca 
S, Russo U, Papapietro VR, Splendiani A, Di Cesare E, 
Masciocchi C, Barile A. Developments in the management 
of bone metastases with interventional radiology. Acta 
Biomed 2018;89:166-74.
47. Blomlie V, Rofstad EK, Talle K, Sundfor K, Winderen M, 
Lien HH. Incidence of radiation-induced insufficiency 
fractures of the female pelvis: evaluation with MR imaging. 
AJR Am J Roentgenol 1996;167:1205-10.
48. Abe H, Nakamura M, Takahashi S, Maruoka S, Ogawa 
Y, Sakamoto K. Radiation-induced insufficiency 
fractures of the pelvis: evaluation with 99mTc-methylene 
diphosphonate scintigraphy. AJR Am J Roentgenol 
1992;158:599-602.
